首页> 外文期刊>Chemistry Select >Design, Synthesis and In-Vitro Antitumor Activity of Lupeol Derivatives via Modification at C-3 and C-30 Positions
【24h】

Design, Synthesis and In-Vitro Antitumor Activity of Lupeol Derivatives via Modification at C-3 and C-30 Positions

机译:通过在C-3和C-30位置进行修饰,Lupeol衍生物的设计,合成和体外抗肿瘤活性

获取原文
获取原文并翻译 | 示例
           

摘要

Lupeol has been isolated from ethanol extract of stem bark of Bombax ceiba through normal phase column chromatography. Total fourteen derivatives of lupeol were synthesized and assayed for in vitro antitumor activities against MDA MB-231, HeLa and A549 cell lines. In cell proliferation experiments, pyrimidine-2(5H)-thione derivative (15) was found to be most potent and significantly inhibited all three tested cancer cell lines i.e. MDA MB-231 (IC50 27.132.13), HeLa (IC50 45.95 1.42) and A549 (IC50 46.270.9). The (2, 4-dinitrophenyl) hydrazyl-3-lupeol Derivative (12) exhibited antitumor activity against MDA MB-231 (IC50 35.881.9) and HeLa cells (IC50 31.911.6) whereas (2, 4-dinitrophenyl)-2H-imidazole deriva- tive (14) showed activity against MDA MB-231 (IC50 38.051.9) and A549 (IC50 42.010.90) cells respectively. Structure activity relationship is also described. Our study showed that com- pound 15 exhibited promising activity against MDA MB-231 and A549 cancer cell lines.
机译:通过正常相柱色谱法,已从Bombax Ceiba的茎皮的乙醇提取物中分离出Lupeol。 合成了14种卢底酚的衍生物,并分析了针对MDA MB-231,HELA和A549细胞系的体外抗肿瘤活性。 在细胞增殖实验中,发现嘧啶-2(5H) - 硫代衍生物(15)最有效,并且显着抑制了所有三个测试过的癌细胞系,即MDA MB-231(IC50 27.132.13),HELA(IC50 45.95 1.42) 和A549(IC50 46.270.9)。 (2,4-二硝基苯基)肼-3-卢比衍生物(12)表现出针对MDA MB-231(IC50 35.881.9)和HELA细胞(IC50 31.911.6)的抗肿瘤活性 -Imidazole衍生物(14)分别显示了对MDA MB-231(IC50 38.051.9)和A549(IC50 42.010.90)细胞的活性。 还描述了结构活动关系。 我们的研究表明,Compount 15对MDA MB-231和A549癌细胞系表现出令人鼓舞的活性。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号